Safety and Efficacy of Subcutaneous Immunoglobulin as Maintenance Therapy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Meta-analysis of Randomized Controlled Trials (P10-11.021)
To evaluate the safety and efficacy of subcutaneous immunoglobulin (SCIg) as a maintenance therapy for patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) by analyzing data from randomized controlled trials (RCTs).
Authors
- Muhammad Ismail Khalid Yousaf (ORCID: https://orcid.org/0000-0002-9111-1763)
- Noman Khalid (ORCID: https://orcid.org/0000-0002-2531-3543)
- Muhammad Hussain
- Salman Muddassir
- Hania Sana
- A. Mushtaq (ORCID: https://orcid.org/0000-0003-4575-145X)
- Bilal Ahmad (ORCID: https://orcid.org/0000-0003-0073-9166)
- Tooba Sana
- Muhammad Abdullah (ORCID: https://orcid.org/0009-0001-4597-1412)
- Natalya Ahsan
Institutions
- King Edward Medical University (PK)
- University Medical Center (US)
- Carilion Clinic (US)
- Virginia Tech (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210864
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00